Targeting chemokines in proteinuria-induced renal disease.

Targeting chemokines in proteinuria-induced renal disease.

Item
http://www.wikidata.org/entity/Q38026076
Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System BlockadePresent and future in the treatment of diabetic kidney diseaseNon-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease.Inflammatory Cytokines as Uremic Toxins: "Ni Son Todos Los Que Estan, Ni Estan Todos Los Que Son".Identification of aberrant gene expression associated with aberrant promoter methylation in primordial germ cells between E13 and E16 rat F3 generation vinclozolin lineageRole of chemokines in proteinuric kidney disorders.Therapeutic approaches to diabetic nephropathy--beyond the RAS.Inhibition of T-cell activation by the CTLA4-Fc Abatacept is sufficient to ameliorate proteinuric kidney disease.Targeting inflammation in diabetic kidney disease: early clinical trials.Gremlin regulates renal inflammation via the vascular endothelial growth factor receptor 2 pathway.TGF-Beta Blockade Increases Renal Inflammation Caused by the C-Terminal Module of the CCN2.
P2860

Targeting chemokines in proteinuria-induced renal disease.

Item
http://www.wikidata.org/entity/Q38026076
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeting chemokines in proteinuria-induced renal disease.
@en
type
label
Targeting chemokines in proteinuria-induced renal disease.
@en
prefLabel
Targeting chemokines in proteinuria-induced renal disease.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Targeting chemokines in proteinuria-induced renal disease.
@en
P2093
P2860
P304
P31
P356
10.1517/14728222.2012.703657
P407
P433
P478
P50
P577
P698